PABLO
ROJO CONEJO
Profesor titular de universidad
MRC Clinical Trials Unit
Londres, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von MRC Clinical Trials Unit (3)
2021
2017
2011
-
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial
The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283